93 reports

Key Features of the Report: - Brain Cancer Patient Flow - Brain Cancer Prevalence - Brain Cancer Diagnosed Patients - Brain Cancer Treated Patients

  • Brain Cancer
  • Cancer
  • Europe
  • World
  • Forecast

Brain Cancer Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Brain Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Brain Cancer pipeline products,

  • Brain Cancer
  • Cancer
  • France
  • Germany
  • Market Size

Key Features of the Report: - Brain Cancer Patient Flow - Brain Cancer Prevalence - Brain Cancer Diagnosed Patients - Brain Cancer Treated Patients

  • Brain Cancer
  • Europe
  • France
  • Germany
  • Forecast
  • Brain Cancer Treatment Drugs Sales Volume
  • Major Foreign Investment in China
  • Brain Cancer
  • China
  • Demand
  • ACON Biotech Co., Ltd
  • Bayer Schering Pharmaceutical Co., Ltd

Brain Cancer Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Brain Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Brain Cancer pipeline products, Brain

  • Brain Cancer
  • Europe
  • France
  • Germany
  • Market Size

Japan Brain Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Brain Cancer Treatments ##) Brain Cancer Pipeline ##) Japan Brain Cancer Epidemiology ##) Marketed Drug

  • Brain Cancer
  • Cancer
  • Pathology
  • Japan
  • Market Size

France Brain Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Brain Cancer Treatments ##) Brain Cancer Pipeline ##) France Brain Cancer Epidemiology ##) Marketed Dr

  • Brain Cancer
  • Cancer
  • Pathology
  • France
  • Market Size

Italy Brain Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Brain Cancer Treatments ##) Brain Cancer Pipeline ##) Italy Brain Cancer Epidemiology ##) Marketed Drug

  • Brain Cancer
  • Cancer
  • Pathology
  • Italy
  • Market Size

Germany Brain Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Brain Cancer Treatments ##) Brain Cancer Pipeline ##) Germany Brain Cancer Epidemiology ##) Marketed

  • Brain Cancer
  • Cancer
  • Pathology
  • Germany
  • Market Size

UK Brain Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Brain Cancer Treatments ##) Brain Cancer Pipeline ##) UK Brain Cancer Epidemiology ##) Marketed Drugs for

  • Brain Cancer
  • Cancer
  • Pathology
  • United Kingdom
  • Market Size

US Brain Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Brain Cancer Treatments ##) Brain Cancer Pipeline ##) US Brain Cancer Epidemiology ##) Marketed Drugs for

  • Brain Cancer
  • Cancer
  • Pathology
  • Market Size

Spain Brain Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Brain Cancer Treatments ##) Brain Cancer Pipeline ##) Spain Brain Cancer Epidemiology ##) Marketed Drug

  • Brain Cancer
  • Cancer
  • Pathology
  • Spain
  • Market Size

2024 ## Figure ##: ##MM, Diagnosed Incident Cases of Brain Cancer by Type, All Ages, Both Sexes, N, 2014 ## EpiCast Report: Brain Cancer - Epidemiology Forecast to 2024 Summary Primary brain cancer is defined as a malignant neoplasm that originat

  • Brain Cancer
  • Cancer
  • Pathology
  • United States
  • Forecast
  • 18.1 Competitive Scenario
  • 05. Introduction

Introduction Glioblastoma multiforme is a variant of brain cancer, and is one of the most aggressive diseases.

  • Brain Cancer
  • Arbor Pharmaceuticals, LLC
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Chapter IV
  • Pricing Trend

Although such growths are popularly called brain tumors, not all brain tumors are cancer.

  • Brain Cancer
  • China
  • Beijing Novartis Pharma Ltd
  • Chongqing Huapont Pharm Co., Ltd
  • Hainan General Sanyang Pharmaceutical Co., Ltd

Welcome to having the world of brain cancer at your fingertips with " Target Atlas in Brain Cancer: A Competitive Outlook"!

  • Brain Cancer
  • Cancer
  • Major Foreign Investment in China
  • Brain Cancer Treatment Drugs Sales Volume by Drugs Classification in 2016(percent)
  • Brain Cancer
  • China
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • DESCRIPTION OF BRAIN CANCER TYPES
  • 4.5 EPIDEMIOLOGICAL FORECAST FOR BRAIN CANCER (2014-2024)
  • Brain Cancer
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Celldex Therapeutics, Inc.
  • Tocagen Inc.

The market is expected to pose lucrative growth over the forecast period, owing to increasing incidence of various brain cancers, particularly glioblastoma, coupled with rising geriatric population.

  • Brain Cancer
  • Therapy
  • Forecast
  • Jul 05, 2016: Potential drug target identified for deadly brain cancer
  • Sep 05, 2017: Zika virus selectively infects and kills glioblastoma cells in mice
  • Brain Cancer
  • Infectious Disease
  • Therapy
  • United States
  • GlobalData's company
  • Comprehensive Cancer Center, 2015* Trial Title
  • TREATING PATIENTS WITH PROGRESSIVE OR RECURRENT MALIGNANT GLIOMA
  • Brain Cancer
  • World
  • Eisai Co., Ltd.
  • Insys Therapeutics, Inc.
  • Merck & Co., Inc.
  • NANOTHERM - BRAIN CANCER
  • NANOTHERM - BRAIN CANCER - PRODUCT DESCRIPTION
  • Brain Cancer
  • Germany
  • United States
  • Company
  • MagForce AG
  • GLOBAL HEALTHCARE CONFERENCE ON JUNE 9, 2017, AT 10:00AM EDT.
  • TUMORS IN 3 MONTH PFS RATE OF 59 PERCENT, 6 MONTH PFS 18 PERCENT.
  • Brain Cancer
  • United States
  • World
  • Product Initiative
  • AbbVie Inc.
  • LATEST CLINICAL TRIALS NEWS ON BRAIN CANCER
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF BRAIN CANCER TO ONCOLOGY CLINICAL TRIALS
  • Brain Cancer
  • Cancer
  • United States
  • World
  • Product Initiative
  • Deal Type
  • DEBT OFFERING

DCVax-L, targets solid tumor cancers (i. e., cancers in various tissues) such as Glioblastoma multiforme (GBM), the most lethal form of brain cancer.

  • Biotherapeutic
  • Brain Cancer
  • Pharmaceutical
  • United States
  • Northwest Biotherapeutics, Inc.

Brain Cancer Pipeline by Stages ##.

  • Brain Cancer
  • Cancer
  • Pathology
  • Product Initiative
  • 2B3-101 - DRUG PROFILE
  • DNX-2401 - DRUG PROFILE
  • Brain Cancer
  • United States
  • World
  • Product Initiative
  • DNAtrix, Inc.
  • multiforme brain cancer.
  • DCVAX-L - DRUG PROFILE
  • Brain Cancer
  • Cancer
  • Therapy
  • United States
  • Product Initiative
  • JUN 23, 2015: CELLMID COLLABORATION TO TREAT BRAIN CANCER
  • OCT 05, 2016: CELLMID'S MIDKINE ANTIBODIES SHOW ANTI-TUMOR ACTIVITY AGAINST BRAIN CANCER
  • Brain Cancer
  • World
  • Litigation And Patent
  • Product Initiative
  • Cellmid Limited
  • JUN 23, 2015: CELLMID COLLABORATION TO TREAT BRAIN CANCER
  • OCT 05, 2016: CELLMID'S MIDKINE ANTIBODIES SHOW ANTI-TUMOUR ACTIVITY AGAINST BRAIN CANCER
  • Brain Cancer
  • World
  • Litigation And Patent
  • Product Initiative
  • Cellmid Limited